SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-021282
Filing Date
2020-05-05
Accepted
2020-05-05 16:20:31
Documents
52
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q rcus-10q_20200331.htm 10-Q 1575647
2 EX-31.1 rcus-ex311_9.htm EX-31.1 19784
3 EX-31.2 rcus-ex312_6.htm EX-31.2 19655
4 EX-32.1 rcus-ex321_8.htm EX-32.1 9211
5 EX-32.2 rcus-ex322_10.htm EX-32.2 9226
  Complete submission text file 0001564590-20-021282.txt   4751125

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT rcus-20200331.xml EX-101.INS 869705
7 XBRL TAXONOMY EXTENSION SCHEMA rcus-20200331.xsd EX-101.SCH 39951
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE rcus-20200331_cal.xml EX-101.CAL 41232
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE rcus-20200331_def.xml EX-101.DEF 84729
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE rcus-20200331_lab.xml EX-101.LAB 296121
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rcus-20200331_pre.xml EX-101.PRE 203498
Mailing Address 3928 POINT EDEN WAY HAYWARD CA 94545
Business Address 3928 POINT EDEN WAY HAYWARD CA 94545 (510) 694-6200
Arcus Biosciences, Inc. (Filer) CIK: 0001724521 (see all company filings)

IRS No.: 473898435 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38419 | Film No.: 20849168
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences